Application 078877

Type
ANDA
Sponsor
ZYDUS PHARMS USA INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TOPIRAMATETOPIRAMATECAPSULE;ORAL15MGNoNo
002TOPIRAMATETOPIRAMATECAPSULE;ORAL25MGNoNo
003TOPIRAMATETOPIRAMATECAPSULE;ORAL50MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
65841-651topiramatetopiramateCadila Healthcare LimitedANDACurrent
65841-651topiramatetopiramateZydus Lifesciences LimitedANDACurrent
65841-651topiramatetopiramateCadila Healthcare LimitedANDACurrent
65841-651topiramatetopiramateCadila Healthcare LimitedANDACurrent
65841-652topiramatetopiramateCadila Healthcare LimitedANDACurrent
65841-652topiramatetopiramateCadila Healthcare LimitedANDACurrent
65841-652topiramatetopiramateZydus Lifesciences LimitedANDACurrent
65841-652topiramatetopiramateCadila Healthcare LimitedANDACurrent
68382-004topiramatetopiramateZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-004topiramatetopiramateZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-004topiramatetopiramateZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-004topiramatetopiramateZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-004topiramatetopiramateZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-005topiramatetopiramateZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-005topiramatetopiramateZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-005topiramatetopiramateZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-005topiramatetopiramateZydus Pharmaceuticals (USA) Inc.ANDACurrent
68382-005topiramatetopiramateZydus Pharmaceuticals (USA) Inc.ANDACurrent